We are pioneering optoelectronics for neurostimulation medical devices by developing innovations to provide a powerful and versatile neurostimulation technological platform. Products derived from this platform would include a small non metallic encapsulation, wireless fast charging, custom optical lead, photovoltaic cells and an enhanced electrode.
This technology could benefit numerous therapeutic applications (such as drug-resistant epilepsy, sleep apnea or depression).
Yves Jongen becomes Chairman of the Board ad interim
Yves Jongen, currently board member of Synergia Medical, succeeds Reinhard Krickl and becomes Chairman ad interim.
Synergia Medical obtains funding from the European Commission (Horizon 2020)
We are proud to share that our versatile neurostimulation technological platform will enjoy the support of Horizon 2020.
We are in the Accenture Innovation Awards 2018 Top 25
For the last couple of months the Accenture Innovation Awards (AIA) has brought us on a journey. Hereby we are proud to announce that our recent work has made it to the Top 25 Health innovators in the AIA competition!